
Highlights how Codexis platform enables breakthrough biocatalytic processes REDWOOD CITY, Calif.--(CRWENewswire)--Codexis, Inc. (Nasdaq:CDXS), a developer of cost-advantaged processes for the production of biofuels, bio-based chemicals, and pharmaceutical intermediates, today announced that the United States Patent and Trademark Office (USPTO) has granted Codexis’ patent covering the biocataly...





